91 related articles for article (PubMed ID: 9414429)
1. Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA.
Resnicoff M; Tjuvajev J; Rotman HL; Abraham D; Curtis M; Aiken R; Baserga R
J Exp Ther Oncol; 1996 Nov; 1(6):385-9. PubMed ID: 9414429
[TBL] [Abstract][Full Text] [Related]
2. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.
Resnicoff M; Sell C; Rubini M; Coppola D; Ambrose D; Baserga R; Rubin R
Cancer Res; 1994 Apr; 54(8):2218-22. PubMed ID: 8174129
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA.
Resnicoff M; Li W; Basak S; Herlyn D; Baserga R; Rubin R
Cancer Immunol Immunother; 1996 Jan; 42(1):64-8. PubMed ID: 8625368
[TBL] [Abstract][Full Text] [Related]
4. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.
Resnicoff M; Burgaud JL; Rotman HL; Abraham D; Baserga R
Cancer Res; 1995 Sep; 55(17):3739-41. PubMed ID: 7641185
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
6. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
[TBL] [Abstract][Full Text] [Related]
7. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
[TBL] [Abstract][Full Text] [Related]
8. IGF-I triple helix gene therapy of rat and human gliomas.
Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
[TBL] [Abstract][Full Text] [Related]
10. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression.
Gunnersen JM; Spirkoska V; Smith PE; Danks RA; Tan SS
Glia; 2000 Nov; 32(2):146-54. PubMed ID: 11008214
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
[TBL] [Abstract][Full Text] [Related]
12. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
Lafarge-Frayssinet C; Duc HT; Frayssinet C; Sarasin A; Anthony D; Guo Y; Trojan J
Cancer Gene Ther; 1997; 4(5):276-85. PubMed ID: 9345599
[TBL] [Abstract][Full Text] [Related]
13. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.
Trojan J; Johnson TR; Rudin SD; Ilan J; Tykocinski ML; Ilan J
Science; 1993 Jan; 259(5091):94-7. PubMed ID: 8418502
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
16. MR imaging in rat glioma model and gene therapy using EGFR antisence RNA.
Zhang Y; Cui J; Liu X; Pu P; Wang G; Wu E
Chin Med J (Engl); 1998 Nov; 111(11):993-7. PubMed ID: 11189225
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
18. VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.
Ke LD; Shi YX; Yung WK
Cancer Res; 2002 Mar; 62(6):1854-61. PubMed ID: 11912165
[TBL] [Abstract][Full Text] [Related]
19. Mutant IGF-I receptors as dominant negatives for growth and transformation.
Burgaud JL; Resnicoff M; Baserga R
Biochem Biophys Res Commun; 1995 Sep; 214(2):475-81. PubMed ID: 7677754
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
